Search

everythinglearnresearchcommunity

for

Search:↓

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

Anterolateral leg alopecia is a benign, nonprogressive hair loss condition on the lower legs that is not well understood and may resolve on its own.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Lymphoma should be considered in unusual scalp hair loss cases, as treatment can work but may lead to severe complications.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

People with Lichen Planus have thicker carotid artery walls, but it's not solely due to Lichen Planus when other factors are considered.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

A new EDA gene variant causes X-linked hypohidrotic ectodermal dysplasia in a Chinese family.

Low-Level Laser Therapy might be a good alternative for hair loss when other treatments fail, but its effectiveness varies and more research is needed.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Patients with limited English prefer professional language interpretation in otolaryngology clinics.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

Certain long non-coding RNAs are important for controlling hair growth cycles in sheep.

Low-level light therapy can safely and effectively stimulate hair growth in people with androgenetic alopecia.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Lipedematous scalp may be underdiagnosed and doesn't improve with finasteride.

Chemotherapy caused nail grooves and separation, but they healed after treatment stopped.

Buschke-Ollendorff syndrome is a rare genetic disorder causing skin and bone changes, with some cases also showing ADHD or developmental delays.

The lotion with N793 strain significantly increased hair density and reduced hair loss safely.

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

Lipid nanoparticles improve treatment delivery and are key to future therapies, but challenges in manufacturing and safety remain.

Hair loss on the lower legs is common in middle-aged men, usually harmless, and doesn't need treatment.

Lymphoid-specific helicase (Lsh) is crucial for skin growth, change, and healing after injury.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Loricrin affects skin immune function and homeostasis.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.